期刊文献+

重组葡萄球菌B型肠毒素超抗原的制备及抗肿瘤活性分析 被引量:7

Study on expression, purification and anti-tumor activity of staphylococcal enterotoxin B
下载PDF
导出
摘要 目的 采用基因工程技术制备葡萄球菌B型肠毒素 (SEB) ,并对其体内外抗肿瘤活性进行分析。方法 对SEB在大肠杆菌中进行高效表达和分离纯化 ,并对其超抗原活性和免疫学活性与天然SEB进行比较研究。观察重组SEB对人肝癌细胞的体外抑制作用 ,以及对小鼠肝癌和肉瘤的体内抑瘤效果。结果 SEB获得高效表达 ,并一步将其纯化至均质。与天然毒素相比较 ,重组SEB的免疫学活性与超抗原活性基本相似。首次证明 ,即使SEB的浓度为 10ng/L ,仍然对人肝癌细胞有显著地抑制作用 ,其对小鼠体内的肝癌和肉瘤有一定的抑制作用。结论 重组SEB在体内外均有一定肿瘤抑制作用 。 Aim To express staphylococcal enterotoxin B(SEB) and analyse its anti tumor activity. Methods SEB gene fragment was inserted into the prokaryotic expression vector pBV220 for efficient expression in E.coli . The expressed product was purified by CM Sepharose FF ion exchange chromatography. The superantigen and anti tumor activities of recombinant SEB were also analysed. Results The recombinant toxin was expressed efficiently in E. coli and SEB of high purity was obtained. The expressed toxin possessed the same superantigen activity as the natural toxin. It was demonstrated for the first time that even 10 ng/L of SEB could inhibit notably the growth of human hepatocellular carcinoma in vitro . Recombinant SEB can also inhibit the tumor growth in vivo . Conclusion The recombinant SEB could inhibit the tumor growth both in vitro and in vivo and may be a potential immuno therapeutic drug of tumor.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2002年第4期323-326,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助 No .3 0 1710 91
关键词 葡萄球菌B型肠毒素 超抗原 表达 纯化 肝细胞癌 staphylococcal enterotoxin B superantigen expression purification hepatocellular carcinoma
  • 相关文献

参考文献3

二级参考文献27

  • 1胡川闽,刘彦仿,陈志南,隋延仿,仇凯,徐力青.两株新的抗肝细胞肝癌单克隆抗体的制备及特异性鉴定[J].单克隆抗体通讯,1994,10(2):16-20. 被引量:7
  • 2刘利,隋延仿,陈志南,刘彦仿.肝癌“双弹头”免疫导向药物的实验研究[J].解放军医学杂志,1994,19(3):167-169. 被引量:3
  • 3Kalland T, Dohlsten M, Lind P, et al Monoclonal antibodies and superantigens: a novel therapeutic approach. Mcd Oncol Tumor Pharmacother, 1993, 10(1-2): 37 被引量:1
  • 4Lando PA, Dohlsten M, Hedlund G, et al. T cellkilling of human colon carcinomas by monoclonal-antibody- targeted superantigens. Cancer Immunol Immunother, 1993, 36 (4): 223 被引量:1
  • 5Dohlsten M, Sundstedt A, Bjorklund M, et al. Superantigen - induced cytokincs suppress growth of human colon-carcioma cellss. Int J Caner, 1993, 54 (3)482 被引量:1
  • 6Ochi A, Migita K, Xu J, et al. In vivo tumor immunotherapy by a bacterial superantigen. J Immunol,1993, 151 (6): 3180 被引量:1
  • 7Shu S, Krinock RA, Matsumura T, et al. Stimulation of tumor- draining lymph onde cells with superantigenic staphylococcal toxins leads to the generation of turnor- specific effector T cells. J Immunol, 1994,152 (3): 1277 被引量:1
  • 8Belfrage H, Bhiladvala P, Hedlund G, et a1. Combined activation of murine lymphocytes with staphylococcal cnterotoxin and interleukin - 2 results in additive cytotoxic activity. Cancer Immunol Immunother,1994, 38 (4): 265 被引量:1
  • 9Norrby- Teglund A, Norgren M, Holm SE, et al.Similar cytokine induction profiles of a movel streptococcal cxotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun, 1994, 62 (9): 3731 被引量:1
  • 10Dohlsten M, Abrahmsen L, Bjork P, Monoclonal antibody- superantigen fusion proteins: tumor- specific agents for T - cell - based tumor therapy. Proc Natl Acad Sci USA, 1994, 91 (19): 8945 被引量:1

共引文献36

同被引文献68

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部